Shares of Quince Therapeutics, Inc. (QNCX) are moving up about 8 percent on Monday morning trading after the company announced the settlement of its outstanding obligations under its loan from the European Investment Bank for a payment of $5.5 million.
The company's shares are currently trading at $0.09 on the Nasdaq, up 8.79 percent. The stock opened at $0.1133. Over the past year, it has traded in a range of $0.08 to $4.55.
The completion of debt settlement resolves critical debt obligations, allowing the company to advance its restructuring and evaluation of strategic alternatives to maximize shareholder value.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.